AQST - Aquestive Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.89 0.59 (8.56%) --- 0.06 (0.81%) 0.14 (1.91%) 0.11 (1.6%) 0.34 (4.79%) 0.0 (0.0%) 0.0 (0.0%)

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.14
Diluted EPS:
-0.14
Basic P/E:
-53.4279
Diluted P/E:
-53.4279
RSI(14) 1m:
100.0
VWAP:
7.48
RVol:
1.1835

Events

Period Kind Movement Occurred At

Related News